Chronic treatment with HDAC inhibitors and the genetic knock down of HDAC improved cognitive function in wild-type and AD model mice via transcriptional mechanisms that led to a long-lasting alteration in gene expression related to synaptic function (Rumbaugh et al., 2015). This evidence concerns the gene HDAC9 and Alzheimer disease.